Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Uterine Cervical Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Hematologic Neoplasms 2 Glioblastoma 2 Carcinoma, Renal Cell 2 Advanced Malignant Solid Neoplasm 2 Vaginal Neoplasms 1 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Tongue Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Rhabdomyosarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pinealoma 1 Pancreatic Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Neuroblastoma 1 Neoplasms 1 Myelodysplastic Syndromes 1 Metastatic Pancreatic Adenocarcinoma 1 Meningeal Carcinomatosis 1 Melanoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Solid Tumors × adavosertib × Clear all

NCT01748825 2021-07-26

AZD1775 for Advanced Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed

67 enrolled 24 charts

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡